RecruitingNot ApplicableNCT06423963

Remote Exercise and Nutritional Prehabilitation for Pancreatic Cancer


Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Enrollment

26 participants

Start Date

Feb 9, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of the study is to examine the feasibility and acceptability of an exercise and nutrition "prehabilitation" program for patients preparing for pancreatic cancer resection (removal).


Eligibility

Min Age: 18 Years

Inclusion Criteria5

  • Age 18 years or older
  • Biopsy-proven pancreatic ductal adenocarcinoma (PDAC), borderline resectable at diagnosis
  • Eastern Cooperative Oncology Group (ECOG) performance status 0-2
  • Undergoing neoadjuvant chemotherapy with treatment plan including chemoradiation therapy and surgical resection
  • Ability to read and speak English

Exclusion Criteria6

  • Regular engagement in RT (2x/week targeting all major muscle groups)
  • Screen failure for exercise safety based on PAR-Q
  • Underlying unstable cardiac or pulmonary disease or symptomatic cardiac disease
  • Recent fracture or acute musculoskeletal injury that precludes ability to participate in RT
  • Numeric pain rating scale greater than or equal to a 7 out of 10
  • Myopathic or rheumatologic disease that impacts physical function

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALPhysical Activity

Each participant will receive a Fitbit device with instruction and encouragement to self-monitor physical activity using step counts.

BEHAVIORALNutrition Counseling

Participants will receive nutritional counseling with a registered dietician.

BEHAVIORALResistance Training

Participants will engage in progressive, full-body resistance training based on American College of Sports Medicine (ACSM) guidelines.


Locations(1)

Moffitt Cancer Center

Tampa, Florida, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06423963


Related Trials